PrimeraDx closes $20 million Series C financing - MarketLine Financial Deals

PrimeraDx closes $20 million Series C financing

PrimeraDx closes $20 million Series C financing - MarketLine Financial Deals
PrimeraDx closes $20 million Series C financing
Published Sep 21, 2009
4 pages — Published Sep 21, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

PrimeraDx, Inc., a US-based molecular diagnostics company, has secured $20 million Series C round of financing led by CHL Medical Partners.

  
Source:
Document ID
MA09435_090923
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "PrimeraDx closes $20 million Series C financing" Sep 21, 2009. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/PrimeraDx-closes-20-million-Series-C-financing-2052-9111>
  
APA:
MarketLine Financial Deals. (2009). PrimeraDx closes $20 million Series C financing Sep 21, 2009. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/PrimeraDx-closes-20-million-Series-C-financing-2052-9111>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.